Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Reiter

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Advances in Cancer Research|June 30, 2001
Recombinant immunotoxins in targeted cancer cell therapyY Reiter
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Antibody engineering of recombinant Fv immunotoxins for improved targeting of cancer: disulfide-stabilized Fv immunotoxinsY Reiter, I Pastan
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1989
Targeting of complement to tumor cells by heteroconjugates composed of antibodies and of the complement component C3bY Reiter, Z Fishelson
Molecular Immunology|June 1, 1992
Complement membrane attack complexes induce in human leukemic cells rapid expression of large proteins (L-CIP)Y Reiter, Z Fishelson
Trends in Biotechnology|January 9, 1999
Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosisY Reiter, I Pastan
Targeted Diagnosis and Therapy|January 1, 1989
Killing of human tumor cells by antibody C3b conjugates and human complementY Reiter, Z Fishelson
European Journal of Immunology|May 1, 1992
Sublytic complement attack protects tumor cells from lytic doses of antibody and complementY Reiter, A Ciobotariu, Z Fishelson
Oncogene|May 29, 2007
Novel antibodies as anticancer agentsI Zafir-Lavie, Y Michaeli, Y Reiter
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2001
Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-peptide tetramers to TCRG Denkberg, C J Cohen, Y Reiter
Nature Biotechnology|October 1, 1996
Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragmentsY Reiter, U Brinkmann, B Lee, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Advances in Cancer Research|June 30, 2001
Recombinant immunotoxins in targeted cancer cell therapyY Reiter
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Antibody engineering of recombinant Fv immunotoxins for improved targeting of cancer: disulfide-stabilized Fv immunotoxinsY Reiter, I Pastan
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1989
Targeting of complement to tumor cells by heteroconjugates composed of antibodies and of the complement component C3bY Reiter, Z Fishelson
Molecular Immunology|June 1, 1992
Complement membrane attack complexes induce in human leukemic cells rapid expression of large proteins (L-CIP)Y Reiter, Z Fishelson
Trends in Biotechnology|January 9, 1999
Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosisY Reiter, I Pastan
Targeted Diagnosis and Therapy|January 1, 1989
Killing of human tumor cells by antibody C3b conjugates and human complementY Reiter, Z Fishelson
European Journal of Immunology|May 1, 1992
Sublytic complement attack protects tumor cells from lytic doses of antibody and complementY Reiter, A Ciobotariu, Z Fishelson
Oncogene|May 29, 2007
Novel antibodies as anticancer agentsI Zafir-Lavie, Y Michaeli, Y Reiter
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2001
Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-peptide tetramers to TCRG Denkberg, C J Cohen, Y Reiter
Nature Biotechnology|October 1, 1996
Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragmentsY Reiter, U Brinkmann, B Lee, et al.
Pageof 4